Evidence map›Paper›PMID 31544130›Full record

ArticleReceptors & clinical investigation2017

CD28 family of receptors inter-connect in the regulation of T-cells.

Janna Krueger, Felix Jules, Sadiye Amcaoglu Rieder, Christopher E Rudd

Open access · diamondAbstract read
In one paragraph

Article in Receptors & clinical investigation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. The Role of the CD28 Family Receptors in T-Cell Immunomodulation.International journal of molecular sciences · 2024
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Janna KruegerDivision of Immunology-Oncology, Hospital Maisonneuve-Rosemont Research Center, Montreal, Quebec H1T 2M4, Canada.
Felix JulesDivision of Immunology-Oncology, Hospital Maisonneuve-Rosemont Research Center, Montreal, Quebec H1T 2M4, Canada.
Sadiye Amcaoglu RiederMedimmune, One MedImmune Way, Gaithersburg, MD 20878, USA.
Christopher E RuddDivision of Immunology-Oncology, Hospital Maisonneuve-Rosemont Research Center, Montreal, Quebec H1T 2M4, Canada.
Université de Montréal · CA

Funding

T Cell Memory in Organ TransplantationR01AI049466 · NIAID · YALE UNIVERSITY · PI LAKKIS, FADI G. · 2001 to 2024
$7.5M
NIAID NIH HHS R01 AI049466
6 · The paper itself

Abstract

T-cell activation is mediated by a combination of signals from the antigen receptor (TCR) and co-receptors such as CD28, cytotoxic T-lymphocyte antigen-4 (CTLA-4), programmed cell death antigen 1 (PD-1), CD28H and others. Each is a member of the CD28 receptor gene family. CD28 sends positive signals that promote T-cell responses, while CTLA-4 and PD-1 limit responses. It is the balance between these positive and negative signals that determines the amplitude and level of T-cell responses. The regulatory role of other family members is also becoming the focus of increasing interest. The function of certain CD28 family members such as CTLA-4 and PD-1 is dependent the expression of CD28. Together, these findings have important implications in generation of immune responses and the application of anti-receptor blocking reagents in immunotherapy.

Indexed as

CD28CD28HCo-receptorsCTLA-4PD-1

Identifiers

PMID31544130
PMCPMC6753945
OpenAlexW2759434639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.